World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
58
Citations
20196
World Ranking
4090
National Ranking
159

Best Publications

  • Cytokines sing the blues: inflammation and the pathogenesis of depression

    Charles L. Raison;Lucile Capuron;Andrew H. Miller

  • Immune System to Brain Signaling: Neuropsychopharmacological Implications

    Lucile Capuron;Andrew H. Miller

  • Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions

    Lucile Capuron;Jane F Gumnick;Dominique L Musselman;David H Lawson

  • Cytokines and psychopathology: Lessons from interferon-α

    Lucile Capuron;Andrew H. Miller

  • Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer

    Andrew H. Miller;Sonia Ancoli-Israel;Julienne E. Bower;Lucile Capuron

  • Neuropsychiatric Adverse Effects of Interferon-α Recognition and Management

    Charles L. Raison;Marina F Demetrashvili;Lucile Capuron;Andrew H Miller

  • Interferon-alpha–induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment

    Lucile Capuron;Gabriele Neurauter;Dominique L Musselman;David H Lawson

  • Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

    L Capuron;A Ravaud;P J Neveu;A H Miller

  • Association of Exaggerated HPA Axis Response to the Initial Injection of Interferon-Alpha With Development of Depression During Interferon-Alpha Therapy

    Lucile Capuron;Charles L. Raison;Dominique L. Musselman;David H. Lawson

  • Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.

    Charles L. Raison;Andrey S. Borisov;Sherry D. Broadwell;Lucile Capuron

  • Dopaminergic Mechanisms of Reduced Basal Ganglia Responses to Hedonic Reward During Interferon Alfa Administration

    Lucile Capuron;Giuseppe Pagnoni;Daniel F. Drake;Bobbi J. Woolwine

  • Chronic Low-Grade Inflammation in Elderly Persons Is Associated with Altered Tryptophan and Tyrosine Metabolism: Role in Neuropsychiatric Symptoms

    Lucile Capuron;Sebastian Schroecksnadel;Catherine Féart;Agnès Aubert

  • Cytokines and depression: the need for a new paradigm.

    Lucile Capuron;Robert Dantzer

  • The neuroimmune basis of fatigue

    Robert Dantzer;Cobi Jacoba Johanna Heijnen;Annemieke Kavelaars;Sophie Laye

  • Early Depressive Symptoms in Cancer Patients Receiving Interleukin 2 and/or Interferon Alfa-2b Therapy

    Lucile Capuron;Alain Ravaud;Robert Dantzer

  • Association of childhood trauma with cognitive function in healthy adults: a pilot study

    Matthias Majer;Matthias Majer;Urs M Nater;Urs M Nater;Jin-Mann S Lin;Lucile Capuron

  • Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.

    Lucile Capuron;Alain Ravaud;Andrew H Miller;Robert Dantzer

  • Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon- α Therapy

    Lucile Capuron;Giuseppe Pagnoni;Marina F Demetrashvili;David H Lawson

  • Depressive Symptoms and Metabolic Syndrome: Is Inflammation the Underlying Link?

    Lucile Capuron;Lucile Capuron;Shaoyong Su;Andrew H. Miller;J. Douglas Bremner

  • Anterior cingulate activation and error processing during interferon-alpha treatment.

    Lucile Capuron;Giuseppe Pagnoni;Marina Demetrashvili;Bobbi J. Woolwine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: